Friday, October 14, 2016 - 17:15
Read this exciting open access article from « Clinical Chemistry and Laboratory Medicine” on the monitoring of multiple myeloma patients treated with daratumumab (Christopher McCudden and Amy E. Axe, Janssen Research & Development). BARC Central Lab was happy to contribute to this study bringing its unique expertise on multiple myeloma.
